search
Back to results

Annatto-derived GG for Statin-associated Myopathy (GG-statin)

Primary Purpose

Myopathy; Primary

Status
Recruiting
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Placebo
Low GG
High GG
Sponsored by
Texas Tech University Health Sciences Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Myopathy; Primary

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age ≥40 of either sex
  • Statin-treated patients with muscle pain alone or accompanied by other symptoms.
  • Patients currently receiving a statin who developed new-onset myalgias in within 90 day of initiation or a dosage increase

Exclusion Criteria:

  • Malignancy or significant neurological or psychiatric disturbances, including alcohol or drug abuse.
  • Woman who is pregnant, breastfeeding, or of childbearing potential and not taking adequate contraceptive precautions.
  • Had CoQ10 supplement one month before starting the study.
  • Genetic musculoskeletal and neurologic disorder known to affect skeletal muscle metabolism
  • Had steroid medication one month before starting the study.

Sites / Locations

  • Texas Tech University Health Sciences CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Placebo Comparator

Active Comparator

Active Comparator

Arm Label

Placebo

Low GG

High GG

Arm Description

Placebo group: subject will take one pill (150 mg olive oil) after breakfast and another pill (150 mg olive oil) after dinner

LOW GG group: subject will take one pill (150 mg olive oil) after breakfast and another pill (150 mg GG) after dinner

HIGH GG group: subject will take one pill (150 mg GG) after breakfast and another pill (150 mg GG) after dinner

Outcomes

Primary Outcome Measures

SAMS-CI
Statin-Associated Muscle Symptom Clinical Index (SAMS-CI) is to assess muscle pain, muscle weakness, tiredness, and cramps.
BPI
Brief Pain Inventory (BPI) is to assess pain and interference of pain with everyday life.

Secondary Outcome Measures

Lower body isometric strength
Lower body (i.e., predominantly of the quadriceps and hip extensors) isometric strength is measured using a dynamometer
Functional lower body strength
Functional lower body strength is measured using a loaded 50m walk.
Wall-sit test
Wall-sit test (wall-slide test) is to assess static leg strength and endurance, particularly of the quadriceps and hip extensors
Heel raise test
Heel raise test is commonly used to test calf muscle endurance, function, and performance. Single-leg or both-leg raise will be tested while staining on a step bench
blood biomarkers: serum creatinine kinase activity
Creatine kinase is to assess muscle damage.
blood biomarkers: myostatin
Myostatin is to assess muscle damage
blood biomarkers: atrogin 1
atrogin 1 is to assess muscle damage
blood biomarkers: hsCRP
hsCRP is to assess inflammation
blood biomarker: IL-6
IL-6 is to assess inflammation
blood lipid profiles
lipid profiles include total triglycerides, total cholesterol, HDL, and calculated LDL
plasma menaquinone-4 (MK4) + menaquinone-4 (MK7)
MK4 and MK4 are vitamin K2 homologues and are measured by HPLC

Full Information

First Posted
March 9, 2022
Last Updated
December 7, 2022
Sponsor
Texas Tech University Health Sciences Center
search

1. Study Identification

Unique Protocol Identification Number
NCT05312424
Brief Title
Annatto-derived GG for Statin-associated Myopathy
Acronym
GG-statin
Official Title
Effect of Annatto-derived Geranylgeraniol (GG) on Statin-associated Myopathy
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Recruiting
Study Start Date
July 15, 2022 (Actual)
Primary Completion Date
October 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Texas Tech University Health Sciences Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To evaluate the effects of 3-months annatto-derived geranylgeraniol (GG) supplementation on statin-associated skeletal muscle health.
Detailed Description
Statins are widely prescribed cholesterol-lowering oral drugs. The majority of reported adverse effects due to statin include muscle pain, weakness, cramp, and tiredness. CoQ10 supplementation has been widely used to reduce statin-related muscle complaints. Several human studies have been reported with inconsistent effects of CoQ10 on statin-related symptoms. This study is to investigate the role of 3-month annatto-derived geranylgeraniol (GG) in statin-related muscle outcomes in humans. Qualified subjects will be matched by age, gender, and body weight, and then randomly assigned to a no GG group, a low GG dose group, or a high GG dose group. The outcome measures will be assessed at baseline and after 3 months. Muscle-associated measurements will be recorded using subject questionnaires (also follow-up after 3 and 6 months), muscle performance results, and blood samples. We will monitor the safety of subjects after 3 months. Food intake, physical activity, and medication changes will be recorded at baseline and after 3 months. All data will be analyzed statistically.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myopathy; Primary

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
95 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Placebo group: subject will take one pill (150 mg olive oil) after breakfast and another pill (150 mg olive oil) after dinner
Arm Title
Low GG
Arm Type
Active Comparator
Arm Description
LOW GG group: subject will take one pill (150 mg olive oil) after breakfast and another pill (150 mg GG) after dinner
Arm Title
High GG
Arm Type
Active Comparator
Arm Description
HIGH GG group: subject will take one pill (150 mg GG) after breakfast and another pill (150 mg GG) after dinner
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
300 mg olive oil
Intervention Type
Dietary Supplement
Intervention Name(s)
Low GG
Intervention Description
150 mg GG
Intervention Type
Dietary Supplement
Intervention Name(s)
High GG
Intervention Description
300 mg GG
Primary Outcome Measure Information:
Title
SAMS-CI
Description
Statin-Associated Muscle Symptom Clinical Index (SAMS-CI) is to assess muscle pain, muscle weakness, tiredness, and cramps.
Time Frame
change in SAMS-CI at 3 months
Title
BPI
Description
Brief Pain Inventory (BPI) is to assess pain and interference of pain with everyday life.
Time Frame
change in BPI at 3 months
Secondary Outcome Measure Information:
Title
Lower body isometric strength
Description
Lower body (i.e., predominantly of the quadriceps and hip extensors) isometric strength is measured using a dynamometer
Time Frame
change in lower body isometric strength at 3 months
Title
Functional lower body strength
Description
Functional lower body strength is measured using a loaded 50m walk.
Time Frame
change in functional lower body strength at 3 months
Title
Wall-sit test
Description
Wall-sit test (wall-slide test) is to assess static leg strength and endurance, particularly of the quadriceps and hip extensors
Time Frame
change in wall-sit test at 3 months
Title
Heel raise test
Description
Heel raise test is commonly used to test calf muscle endurance, function, and performance. Single-leg or both-leg raise will be tested while staining on a step bench
Time Frame
change in heel raise test at 3 months
Title
blood biomarkers: serum creatinine kinase activity
Description
Creatine kinase is to assess muscle damage.
Time Frame
change in serum creatinine kinase activity at 3 months
Title
blood biomarkers: myostatin
Description
Myostatin is to assess muscle damage
Time Frame
changes in serum myostatin at 3 months
Title
blood biomarkers: atrogin 1
Description
atrogin 1 is to assess muscle damage
Time Frame
changes in serum atrogin 1 at 3 months
Title
blood biomarkers: hsCRP
Description
hsCRP is to assess inflammation
Time Frame
changes in serum hsCRP at 3 months
Title
blood biomarker: IL-6
Description
IL-6 is to assess inflammation
Time Frame
changes in serum IL-6 at 3 months
Title
blood lipid profiles
Description
lipid profiles include total triglycerides, total cholesterol, HDL, and calculated LDL
Time Frame
changes in blood lipid profiles at 3 months
Title
plasma menaquinone-4 (MK4) + menaquinone-4 (MK7)
Description
MK4 and MK4 are vitamin K2 homologues and are measured by HPLC
Time Frame
changes in plasma MK4+MK7 at 3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age ≥40 of either sex Statin-treated patients with muscle pain alone or accompanied by other symptoms. Patients currently receiving a statin who developed new-onset myalgias in within 90 day of initiation or a dosage increase Exclusion Criteria: Malignancy or significant neurological or psychiatric disturbances, including alcohol or drug abuse. Woman who is pregnant, breastfeeding, or of childbearing potential and not taking adequate contraceptive precautions. Had CoQ10 supplement one month before starting the study. Genetic musculoskeletal and neurologic disorder known to affect skeletal muscle metabolism Had steroid medication one month before starting the study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chwan-Li (Leslie) Shen, PhD
Phone
8067432815
Email
leslie.shen@ttuhsc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chwan-Li (Leslie) Shen, PhD
Organizational Affiliation
Texas Tech Health Science Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Texas Tech University Health Sciences Center
City
Lubbock
State/Province
Texas
ZIP/Postal Code
79430
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chwan-Li (Leslie) Shen, PhD
Phone
806-743-2815
Email
Leslie.Shen@ttuhsc.edu
First Name & Middle Initial & Last Name & Degree
Chwan-Li (Leslie) Shen, PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Annatto-derived GG for Statin-associated Myopathy

We'll reach out to this number within 24 hrs